NEW YORK, July 15 (GenomeWeb News) - GE Healthcare's revenues during the second quarter of 2005 increased 12 percent year over year, to $3.8 billion, GE reported today.
The business unit, which incorporated Amersham Biosciences in April of last year, contributed 9 percent to GE's overall quarterly revenues of $41.6 billion, similar to the same period in 2004. GE's total revenues were up 13 percent over last year's $36.8 billion during the second quarter.
Orders for the healthcare business unit grew 11 percent over the second quarter of 2004, to $3.9 billion, $2.5 billion of which came from equipment orders.
Healthcare had $672 million in profits, up 15 percent from $584 million during the same period last year.
GE's total earnings amounted to $4.6 billion, up 24 percent from $3.8 billion in the second quarter of last year. Earnings per share were $.44, up 22 percent over last year's $.36 during the same period.
As of June 30, GE had $146 billion in cash and marketable securities.